Xometry stock has delivered very strong returns over the past three years, yet its valuation signals are split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market multiples suggest the shares are expensive. That tension leaves investors weighing a 27.0% implied discount to intrinsic value against a low overall value score.
Xometry has returned about 308.5% over the past three years, which puts unusual weight on whether that performance is already fully reflected in the current share price.
Recent upgrades to Xometry’s AI model architecture may support expectations for better cost accuracy and sourcing efficiency. However, any disappointment in how these upgrades translate into revenue and cash flow could pressure the valuation.
Xometry scores 2 of 6 on Simply Wall St’s broader valuation checks, which suggests the stock does not screen as a clear bargain overall even though some metrics flag potential upside (2/6 valuation score).
The issue now is whether Xometry’s recent gains plus the mixed valuation signals still leave enough margin between the share price and the intrinsic value estimate to appeal to investors.
The Discounted Cash Flow model for Xometry takes projected future free cash flows and discounts them back to today to estimate what the stock might be worth.
On this model, Xometry is currently working through a period of negative free cash flow, with the latest twelve-month figure showing an outflow of about $5.8 million. The projections assume that cash flows recover and grow over time, which feeds into an estimated intrinsic value of about $118 per share. Against the current share price, that implies the stock trades at roughly a 27.0% discount.
Xometry’s recent upgrades to its AI model architecture, including improvements in cost prediction and sourcing speed, help explain why the cash flow forecasts are constructive even though the latest free cash flow is still negative. Despite that progress, the market price has not fully closed the gap to the modelled cash flow value.
On this analysis, Xometry stock currently appears undervalued relative to its estimated value under the Discounted Cash Flow model.
P/S is a useful lens for Xometry because the company is not yet valued on earnings and investors often focus on revenue traction instead. Xometry currently trades on a P/S of about 6.6x, which is well above the Trade Distributors industry average of roughly 1.1x and also higher than the peer group average of about 1.6x. That puts a clear premium on each dollar of Xometry’s sales compared with many other distributors.
The fair P/S ratio implied by Simply Wall St’s model is about 5.5x, based on factors such as the company’s size, margins, growth profile and risks. With the stock at roughly 6.6x sales, Xometry trades ahead of that fair ratio, which signals that the current price already builds in optimistic expectations relative to the company specific benchmark.
Overall, Xometry stock appears expensive on the P/S multiple, with the market pricing its revenues above both industry norms and the model’s fair ratio.
The Xometry Narrative: What Would Justify Today’s Price?
Simply Wall St Narratives pick up where Xometry’s valuation puzzle leaves off by spelling out which future paths for growth, margins and earnings would need to play out for the stock to be worth materially more or less than today’s price. They sit on Simply Wall St’s Community page, and each one links its number to a specific view on how Xometry’s growth, profitability and risks might evolve, giving you a reference point you can revisit as new information emerges.
Xometry’s community narratives sit far apart, with one side focused on AI driven upside and the other on whether expectations have already run too hot.
Bull case: 10% undervalued
“Xometry’s growing network effect, evidenced by its expanding base of buyers and suppliers and increasing share of larger enterprise accounts, is enhancing marketplace liquidity and pricing power…”
“Heavy reliance on AI models and data driven pricing, including the newer lead time and personalization engines, could create pressure on gross margins if prediction errors increase…”
For Xometry, the Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside, while the market multiple view paints the stock as overvalued on sales. That split, together with weak broader valuation checks, suggests the DCF signal needs to be treated with caution rather than as a simple bargain flag. The tension largely comes down to how much faith you put in future cash flow improving versus today’s rich revenue multiple. The crux from here is whether Xometry’s AI driven platform can translate into sustained, higher quality cash generation that justifies both the DCF upside and the premium P/S.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
